Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.

Gilca R, Deceuninck G, Lefebvre B, Tsang R, Amini R, Gilca V, Douville-Fradet M, Markowski F, De Wals P.

PLoS One. 2012;7(11):e50659. doi: 10.1371/journal.pone.0050659. Epub 2012 Nov 29.

2.

Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.

Neri A, Pezzotti P, Fazio C, Vacca P, D'Ancona FP, Caporali MG, Stefanelli P.

PLoS One. 2015 Oct 7;10(10):e0139376. doi: 10.1371/journal.pone.0139376. eCollection 2015.

3.

Australian Meningococcal Surveillance Programme annual report, 2015.

Lahra MM, Enriquez RP; National Neisseria Network.

Commun Dis Intell Q Rep. 2016 Dec 24;40(4):E503-E511.

4.

Australian Meningococcal Surveillance Programme annual report, 2014.

Lahra MM, Enriquez RP.

Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E221-8.

5.

Serogroup C meningococci in Italy in the era of conjugate menC vaccination.

Stefanelli P, Fazio C, Sofia T, Neri A, Mastrantonio P.

BMC Infect Dis. 2009 Aug 22;9:135. doi: 10.1186/1471-2334-9-135.

6.

[Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].

Křížová P, Vacková Z, Musílek M, Kozáková J.

Epidemiol Mikrobiol Imunol. 2013 Dec;62(4):138-47. Czech.

PMID:
24467175
7.

Australian Meningococcal Surveillance Programme annual report, 2013.

Lahra MM, Enriquez RP.

Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E301-8.

8.

Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.

Stoof SP, Rodenburg GD, Knol MJ, Rümke LW, Bovenkerk S, Berbers GA, Spanjaard L, van der Ende A, Sanders EA.

Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.

PMID:
26123933
9.

Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.

Wormsbecker AE, Wong K, Jamieson FB, Crowcroft NS, Deeks SL.

Vaccine. 2015 Oct 13;33(42):5678-5683. doi: 10.1016/j.vaccine.2015.08.023. Epub 2015 Aug 20.

10.

Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.

De Wals P, Deceuninck G, Lefebvre B, Tsang R, Law D, De Serres G, Gilca V, Gilca R, Boulianne N.

Clin Infect Dis. 2017 May 1;64(9):1263-1267. doi: 10.1093/cid/cix154.

PMID:
28207068
11.

Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.

Mattheus W, Hanquet G, Collard JM, Vanhoof R, Bertrand S.

PLoS One. 2015 Oct 1;10(10):e0139615. doi: 10.1371/journal.pone.0139615. eCollection 2015.

12.

Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.

Vickers DM, Anonychuk AM, De Wals P, Demarteau N, Bauch CT.

Vaccine. 2015 Jan 1;33(1):268-75. doi: 10.1016/j.vaccine.2013.09.034. Epub 2013 Oct 6.

13.

Meningococcal disease and vaccination in North America.

Pollard AJ, Scheifele D.

J Paediatr Child Health. 2001 Oct;37(5):S20-7.

PMID:
11885732
14.

[Clonal analysis of the meningococcal populations from invasive disease and healthy carriers isolated in the Czech Republic in 1971-2014 (May)].

Jandová Z, Musílek M, Vacková Z, Kozáková J, Křížová P.

Epidemiol Mikrobiol Imunol. 2015 Sep;64(3):147-52. Czech.

PMID:
26448302
15.

Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.

Bijlsma MW, Bekker V, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A.

Lancet Infect Dis. 2014 Sep;14(9):805-12. doi: 10.1016/S1473-3099(14)70806-0. Epub 2014 Aug 4.

PMID:
25104306
16.

Epidemiology of invasive meningococcal disease in Austria 2010.

Steindl G, Liu YL, Schmid D, Orendi U, Kormann-Klement A, Heuberger S.

Wien Klin Wochenschr. 2011 Oct;123 Suppl 1:10-4. doi: 10.1007/s00508-011-0058-0. Epub 2011 Sep 26.

PMID:
21935643
17.

Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.

Siu T, Tang W, Dawar M, Patrick DM.

Can J Public Health. 2008 Sep-Oct;99(5):380-2.

PMID:
19009920
18.

Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010.

Dang V, Jamieson FB, Wilson S, Rawte P, Crowcroft NS, Johnson K, Tsang RS, Deeks SL.

BMC Infect Dis. 2012 Aug 29;12:202. doi: 10.1186/1471-2334-12-202.

19.

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

Kristiansen PA, Ba AK, Ouédraogo AS, Sanou I, Ouédraogo R, Sangaré L, Diomandé F, Kandolo D, Saga IM, Misegades L, Clark TA, Préziosi MP, Caugant DA.

BMC Infect Dis. 2014 Dec 4;14:663. doi: 10.1186/s12879-014-0663-4.

20.

Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.

Zhou J, Lefebvre B, Deng S, Gilca R, Deceuninck G, Law DK, De Wals P, Tsang RS.

J Clin Microbiol. 2012 May;50(5):1545-51. doi: 10.1128/JCM.06835-11. Epub 2012 Feb 15.

Supplemental Content

Support Center